stage IV squamous cell carcinoma of the oropharynx
Showing 9976 - 10000 of >10,000
Follicular Lymphoma, Low Grade Non-Hodgkin's Lymphoma, Adult Trial in Boston (Epcoritamab, Rituximab)
Not yet recruiting
- Follicular Lymphoma
- Low Grade Non-Hodgkin's Lymphoma, Adult
-
Boston, MassachusettsDana-Farber Cancer Institute
Mar 13, 2023
Cervical Cancer Trial in Shanghai (Autologous Tumor Infiltrating Lymphocytes (C-TIL052A) Injection)
Recruiting
- Cervical Cancer
- Autologous Tumor Infiltrating Lymphocytes (C-TIL052A) Injection
-
Shanghai, Shanghai, China
- +1 more
Jul 26, 2022
Hepatocellular Carcinoma, Liver Cirrhoses Trial in Los Angeles (Pravastatin Pill, Placebo Oral Tablet)
Terminated
- Hepatocellular Carcinoma
- Liver Cirrhoses
- Pravastatin Pill
- Placebo Oral Tablet
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Dec 31, 2020
Locally Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (Induction Chemotherapy, Concurrent Chemotherapy, Definitive
Recruiting
- Locally Advanced Nasopharyngeal Carcinoma
- Induction Chemotherapy
- +2 more
-
Guangzhou, Guang Dong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Sep 21, 2021
Aggressive Non-Hodgkin Lymphoma, CD20 Positive, Recurrent B-Cell Non-Hodgkin Lymphoma Trial in Rochester (Laboratory Biomarker
Suspended
- Recurrent Aggressive Non-Hodgkin Lymphoma
- +5 more
- Laboratory Biomarker Analysis
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 12, 2023
Kidney Failure, Chronic, Chronic Kidney Disease stage3, Chronic Kidney Disease Stage 3B Trial in Lyon (Low-AGE diet, High-AGE
Not yet recruiting
- Kidney Failure, Chronic
- +5 more
- Low-AGE diet
- High-AGE diet
-
Lyon, FranceCentre Hospitalier Saint Joseph Saint Luc
Jan 3, 2022
Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in
Recruiting
- Castration-Resistant Prostatic Cancer
- +4 more
- ARAT
- +2 more
-
Orange City, Florida
- +1 more
Nov 23, 2022
Insulin, Glucose, Healthy Volunteers Trial in Boston (Kisspeptin-10, mixed meal tolerance test)
Recruiting
- Insulin
- +4 more
- Kisspeptin-10
- mixed meal tolerance test
-
Boston, MassachusettsMassachusetts General Hospital
Jul 19, 2022
Periodontitis Trial (PRF)
Not yet recruiting
- Periodontitis
- PRF
- (no location specified)
May 25, 2023
Bedwetting in Children With Sickle Cell Disease
Terminated
- Nocturnal Enuresis
- Anemia, Sickle Cell
-
Bronx, New YorkChildren's Hospital at Montefiore
May 25, 2022
Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)
Active, not recruiting
- Brain and Central Nervous System Tumors
- Induction Chemotherapy
- +3 more
-
Palo Alto, California
- +5 more
Nov 29, 2022
Metabolism, Nutrition Trial in Monserrato (kent'erbas cheese study)
Recruiting
- Metabolism
- Nutrition
- kent'erbas cheese study
-
Monserrato, Cagliari, ItalyUniversity of Cagliari
Aug 26, 2023
Nasopharyngeal Carcinoma Trial in Guangzhou (CCRT+Nimotuzumab, CCRT alone)
Active, not recruiting
- Nasopharyngeal Carcinoma
- CCRT+Nimotuzumab
- CCRT alone
-
Guangzhou, Guangdong, ChinaSun Yat-sen Universitty Cancer Center
Nov 22, 2021
DLBCL Refractory, Diffuse Large B-cell Lymphoma Recurrent Trial in Worldwide (Loncastuximab tesirine)
Completed
- Diffuse Large B-Cell Lymphoma Refractory
- Diffuse Large B-cell Lymphoma Recurrent
- Loncastuximab tesirine
-
Duarte, California
- +36 more
Aug 18, 2022
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,
Recruiting
- Lymphoma, Non-Hodgkin
- +6 more
- CB-010
- +2 more
-
Scottsdale, Arizona
- +7 more
Aug 19, 2022
NSCLC Metastatic Trial in Naestved, Aalborg, Vejle (Circulating tumor DNA treatment monitoring)
Not yet recruiting
- Non-small Cell Lung Cancer Metastatic
- Circulating tumor DNA treatment monitoring
-
Naestved, Zealand, Denmark
- +2 more
May 25, 2023
Graft Vs Host Disease, Graft-versus-host-disease, GVHD Trial in Saint Louis (Ruxolitinib)
Not yet recruiting
- Graft Vs Host Disease
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 18, 2023
Superficial Bladder Cancer Trial in Egypt, Germany (abnobaVISCUM 900, Mitomycin C)
Recruiting
- Superficial Bladder Cancer
- abnobaVISCUM 900
- Mitomycin C
-
Giza, Egypt
- +18 more
Apr 25, 2022
Chronic Kidney Diseases, Sickle Cell Disease Trial in Richmond (No intervention)
Completed
- Chronic Kidney Diseases
- Sickle Cell Disease
- No intervention
-
Richmond, VirginiaVirginia Commonwealth University
Jan 21, 2022
Refractory T-Cell Lymphoma, Relapsed T-Cell Lymphoma Trial in Italy (Daratumumab)
Active, not recruiting
- Refractory T-Cell Lymphoma
- Relapsed T-Cell Lymphoma
-
Bari, Italy
- +6 more
Aug 1, 2022
COVID-19, SARS-CoV-2 Infection Trial in Morelia (Recombinant COVID-19 variant Vaccine (Sf9 Cell), COVID-19 Vaccine (Vero Cell),
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- Recombinant COVID-19 variant Vaccine (Sf9 Cell)
- +3 more
-
Morelia, Michoacán De Ocampo, MexicoClínica de Enfermedades Crónicas y de Procedimientos Especiales,
Jul 18, 2022
(PMS) for the Long-term Safety of VAXZEVRIA
Active, not recruiting
- Prevention of Infectious Disease Caused by SARS-CoV-2
-
Chiba, Japan
- +5 more
Nov 24, 2022
T-cell Non-Hodgkin's Lymphoma Trial (CD147- CAR T cells)
Not yet recruiting
- T-cell Non-Hodgkin's Lymphoma
- CD147- CAR T cells
- (no location specified)
Aug 1, 2022
Testicular Tissue Cryopreservation in Setting of
Recruiting
- Gender Dysphoria
- Transgender
- Infectious Disease Testing
- Gonadal Tissue Removal
-
Pittsburgh, PennsylvaniaMagee-Womens Hospital
Apr 13, 2023